In order to confirm that it is high levels of IL-4 that inhibit the efficacy of immunotherapy, rather than high proliferation of tumor cells after drug resistance and excessive production of IL-4, we verified in animal models that IL-4 can inhibit the efficacy of mouse PD-1 antibody. Here, IL4 is linked to neoplasm.